Axsome Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 11/14/2024 | 4.19 M | $376.52 M | -9.60% | 8.70% |
| VANGUARD GROUP INC | 11/13/2024 | 4.00 M | $359.06 M | 6.77% | 8.30% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.40 M | $305.41 M | 100.00% | 7.06% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2024 | 2.36 M | $212.10 M | 0.00% | 4.90% |
| FMR LLC | 11/13/2024 | 1.09 M | $97.79 M | 20.61% | 2.26% |
| BVF INC/IL | 11/14/2024 | 1.05 M | $94.00 M | 9.53% | 2.17% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 1.00 M | $89.87 M | 0.00% | 2.08% |
| MACQUARIE GROUP LTD | 11/14/2024 | 995,287 | $89.45 M | -7.26% | 2.07% |
| STATE STREET CORP | 11/14/2024 | 916,808 | $82.39 M | -2.31% | 1.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 908,459 | $81.66 M | 2.66% | 1.89% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 857,219 | $77.04 M | -53.73% | 1.78% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 827,887 | $74.40 M | -11.81% | 1.72% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 782,844 | $70.35 M | 70.51% | 1.63% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 742,745 | $66.75 M | 1.11% | 1.54% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 738,503 | $66.37 M | -0.32% | 1.53% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 727,528 | $65.38 M | -18.35% | 1.51% |
| INVESCO LTD. | 11/12/2024 | 625,179 | $56.18 M | 12.07% | 1.30% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 625,084 | $56.18 M | 13.85% | 1.30% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 542,620 | $48.77 M | 13.27% | 1.13% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 525,000 | $47.18 M | -28.08% | 1.09% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 467,427 | $42.01 M | 0.00% | 0.97% |
| MORGAN STANLEY | 11/14/2024 | 410,150 | $36.86 M | 27.38% | 0.85% |
| BOXER CAPITAL, LLC | 11/14/2024 | 400,000 | $35.95 M | 0.00% | 0.83% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 400,000 | $35.95 M | 0.00% | 0.83% |
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 379,527 | $34.11 B | 22.35% | 0.79% |
| BELLEVUE GROUP AG | 11/14/2024 | 367,181 | $33.00 M | -28.91% | 0.76% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 362,625 | $32.59 M | -9.64% | 0.75% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 322,596 | $28.99 M | 4.12% | 0.67% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 320,200 | $28.78 M | 31.77% | 0.67% |
| CITADEL ADVISORS LLC | 11/14/2024 | 304,682 | $27.38 M | -59.55% | 0.63% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 298,586 | $26.83 M | 10.96% | 0.62% |
| WOODLINE PARTNERS LP | 11/14/2024 | 298,569 | $26.83 M | -6.11% | 0.62% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 296,100 | $26.61 M | -21.25% | 0.62% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 255,294 | $22.94 M | -24.30% | 0.53% |
| IRON TRIANGLE PARTNERS LP | 11/14/2024 | 252,266 | $22.67 M | 100.00% | 0.52% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 250,700 | $22.53 M | 34.21% | 0.52% |
| JPMORGAN CHASE & CO | 11/08/2024 | 212,110 | $19.06 M | 14.92% | 0.44% |
| CHECKPOINT CAPITAL L.P. | 11/14/2024 | 209,632 | $18.84 M | -27.91% | 0.44% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 200,000 | $17.97 M | 100.00% | 0.42% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 197,935 | $17.79 M | 336.80% | 0.41% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 160,534 | $13.71 M | 47.50% | 0.33% |
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 150,000 | $13.48 B | 100.00% | 0.31% |
| CITADEL ADVISORS LLC | 11/14/2024 | 138,800 | $12.47 M | 70.31% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 136,446 | $12.26 M | -17.59% | 0.28% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 135,000 | $12.13 M | -10.00% | 0.28% |
| US BANCORP \DE\ | 10/28/2024 | 133,126 | $11.96 M | 0.32% | 0.28% |
| JANE STREET GROUP, LLC | 11/15/2024 | 130,097 | $11.69 M | -22.76% | 0.27% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 10/25/2024 | 126,803 | $11.40 M | -0.08% | 0.26% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 124,978 | $11.23 M | -25.94% | 0.26% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 122,600 | $11.02 M | -3.92% | 0.25% |
Axsome Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 336 institutional investors and hedge funds held shares of Axsome Therapeutics, Inc.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 4.19 M
VANGUARD GROUP INC: 4 M
BlackRock Funding, Inc. /DE: 3.4 M
Fairmount Funds Management LLC: 2.36 M
FMR LLC: 1.09 M
BVF INC/IL: 1.05 M
79.42% of Axsome Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.60 M shares in the last 24 months. This purchase volume represents approximately $3.88 B in transactions.